Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04583579 · ClinicalTrials.gov registry record · NA
Maximizing the Initial Experience of a Neophyte Scleral Lens Wearer
A NA study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04583579: Clinical Trial NA study, sponsored by University of Alabama at Birmingham.
NCT04583579 is a NA study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04583579, a NA study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The goal of this proposal is to conduct a randomized controlled study aimed at learning the best method for applying scleral lenses and factors associated with successfully completing scleral lens application and removal training.
Primary Outcome
Amount of time needed to apply scleral lenses to both eyes (minutes); each patient will try each application method in a random order.
Interventions
- DEVICE DMV inserter (DMV® MagicTouch™) with an open end
- DEVICE DMV inserter (DMV® MagicTouch™) with a closed end
- DEVICE Three fingers (Patient's Hand)
- DEVICE O-ring (Hardware Store Product)
- DEVICE Tea light candle (Generic Deparment Store Product) with DMV inserter (DMV® MagicTouch™)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2021-02-23 |
| Est. Completion | 2023-06-01 |
| Phase | NA |
Why NCT04583579 stopped before completion
NCT04583579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which DMV inserter (DMV® MagicTouch™) with an open end is the first listed.
NCT04583579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04583579 about?
NCT04583579 is a clinical study titled "Maximizing the Initial Experience of a Neophyte Scleral Lens Wearer". The goal of this proposal is to conduct a randomized controlled study aimed at learning the best method for applying scleral lenses and factors associated with successfully completing scleral lens application and removal training.
What is the current status of trial NCT04583579?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2021-02-23. Estimated completion is 2023-06-01.
What interventions are being tested in trial NCT04583579?
The interventions under investigation include: DMV inserter (DMV® MagicTouch™) with an open end (DEVICE), DMV inserter (DMV® MagicTouch™) with a closed end (DEVICE), Three fingers (Patient's Hand) (DEVICE), O-ring (Hardware Store Product) (DEVICE), Tea light candle (Generic Deparment Store Product) with DMV inserter (DMV® MagicTouch™) (DEVICE).
Who is sponsoring clinical trial NCT04583579?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04583579's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI